Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review

Yudai Hinata; Nobumasa Ohara; Yuhki Sakurai; Ryo Koda; Yuichiro Yoneoka; Toshinori Takada; Noboru Hara; Tsutomu Nishiyama

doi:10.12659/AJCR.931639

15 July 2021 : Case report Japan

Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review

Unusual clinical course

Yudai Hinata^1BCD, Nobumasa Ohara^1ABCDEF*, Yuhki Sakurai^1CD, Ryo Koda^2BCD, Yuichiro Yoneoka^3CD, Toshinori Takada^4CD, Noboru Hara^5BD, Tsutomu Nishiyama^5BD

DOI: 10.12659/AJCR.931639

Am J Case Rep 2021; 22:e931639

Authors information Article notes Copyright and License information

Background Case Report Discussion Conclusions References:

Related articles Order reprints Share article Share by email

View HTML version

Figure 1. Magnetic resonance imaging (MRI) of the brain. Plain MRI scans obtained in August 2019 (A: T1-weighted image; C: T2-weighted image) and in November 2019 (B: T1-weighted image; D: T2-weighted image) show no abnormalities in the hypothalamus, hypophyseal stalk, or pituitary gland (arrows).

Back to the Article

Isolated Adrenocorticotropic Hormone Deficiency Associated with Severe Hyperkalemia During Pembrolizumab Therapy in a Patient with Ureteral Cancer and an Ileal Conduit: A Case Report and Literature Review

Your Privacy